Ready-to-administer injectables… and Canadian!
With the COVID-19 pandemic, it is all of Canada that realizes how dependent we are on foreign companies when it’s time to order drugs. Fortunately, pharmaceutical companies like Sterinova are there to develop and offer products, made here, and that meet the needs of our healthcare professionals
Committed to offering quality products, Sterinova’s injectable medications have a stability of two years at room temperature, are safe and facilitate your work. Nothing to prepare, just to unpack!
Products developed at Sterinova are following the evolution of our customer needs. Special attention is given to the choice of concentrations, total doses, formats and diluents. Moreover, we focus our product development to forms that are stable at room temperature.
Our ready-to-administer products represent the following advantages compared to injectable compounding preparations.
Increased Security:
- Dosage standardization to reduce the risk of medication error
- Products manufactured according to current Good Manufacturing Practice (GMP) guidelines that ensures high quality
- The use of our products reduces the risk of incidents compared to products that need to be prepared under a hood or at the patient’s bedside.
Accuracy:
- Our products allow clinicians to administer an accurate dose effectively.
Increased stability:
- Stability is longer than current sterile compounded preparations
- Stability at room temperature
Facilitates inventory management:
- Reduction of the administrative and cost impact associated with the destruction of expired products.
Workflow (reduced number of incidents):
- Reduces the need of technical pharmacy technicians that can be redeployed to value added tasks instead of working on repetitive manipulations to prepare syringes or bags from ampoules or vials. Our products save time and improve your workflow.